NDC 0268-0134

CENTER-AL - DACTYLIS GLOMERATA POLLEN

Dactylis Glomerata Pollen

CENTER-AL - DACTYLIS GLOMERATA POLLEN is a Subcutaneous Injection, Suspension in the Non-standardized Allergenic category. It is labeled and distributed by Alk-abello, Inc.. The primary component is Dactylis Glomerata Pollen.

Product ID0268-0134_3e57188f-318a-4ebf-902d-a9ff158f98d2
NDC0268-0134
Product TypeNon-standardized Allergenic
Proprietary NameCENTER-AL - DACTYLIS GLOMERATA POLLEN
Generic NameDactylis Glomerata Pollen
Dosage FormInjection, Suspension
Route of AdministrationSUBCUTANEOUS
Marketing Start Date1975-01-15
Marketing CategoryBLA / BLA
Application NumberBLA103753
Labeler NameALK-Abello, Inc.
Substance NameDACTYLIS GLOMERATA POLLEN
Active Ingredient Strength20000 [PNU]/mL
Pharm ClassesStandardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0268-0134-10

10 mL in 1 VIAL, MULTI-DOSE (0268-0134-10)
Marketing Start Date1975-01-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0268-0134-10 [00268013410]

CENTER-AL - DACTYLIS GLOMERATA POLLEN INJECTION, SUSPENSION
Marketing CategoryBLA
Application NumberBLA103753
Product TypeNON-STANDARDIZED ALLERGENIC
Marketing Start Date1975-01-15

Drug Details

Active Ingredients

IngredientStrength
DACTYLIS GLOMERATA POLLEN20000 [PNU]/mL

Pharmacological Class

  • Standardized Pollen Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Pollen [CS]
  • Allergens [CS]

NDC Crossover Matching brand name "CENTER-AL - DACTYLIS GLOMERATA POLLEN" or generic name "Dactylis Glomerata Pollen"

NDCBrand NameGeneric Name
0268-0134CENTER-AL - DACTYLIS GLOMERATA POLLENDACTYLIS GLOMERATA POLLEN
54575-097STANDARDIZED ORCHARD GRASS POLLENDactylis glomerata pollen

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.